Natural Science
Vol.4 No.12A(2012), Article ID:26151,14 pages DOI:10.4236/ns.2012.412A142

Review. Comparative structures and evolution of mammalian lipase I (LIPI) genes and proteins: A close relative of vertebrate phospholipase LIPH*

Roger S. Holmes1,2#, Laura A. Cox1

1Department of Genetics and Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, USA; #Corresponding Author: r.holmes@griffith.edu.au

2Eskitis Institute for Cell and Molecular Therapies, Griffith University, Nathan, Australia

Received ************* 2012

Keywords: Mammalian LIPI Genes and Proteins; Amino Acid Sequence; Lipase I; Evolution; Phylogeny

ABSTRACT

Lipase I (enzyme name LIPI or LPDL) (gene name LIPI [human] or Lipi [mouse]) is a phospholipase which generates 2-acyl lysophosphatidic acid (LPA), a lipid mediator required for maintaining homeostasis of diverse biological functions and in activating cell surface receptors. Bioinformatic methods were used to predict the amino acid sequences, secondary and tertiary structures and gene locations for LIPI genes and encoded proteins using data from several mammalian genome projects. LIPI is located on human chromosome 21 and is distinct from other phospholipase A1-like genes (LIPH and PS-PLA1). Mammalian LIPI genes contained 10 (human) or 11 (mouse) coding exons transcribed predominantly on the negative DNA strand. Mammalian LIPI protein subunits shared 61% - 99% sequence identities and exhibited sequence alignments and identities for key LIPI amino acid residues as well as extensive conservation of predicted secondary and tertiary structures with those previously reported for pancreatic lipase (PL), with “N-signal peptide”, “lipase” and “plat” structural domains. Comparative studies of mammalian LIPI sequences with LIPH, PS-PLA1 and pancreatic lipase (PL) confirmed predictions for LIPI Nterminal signal peptides (residues 1 - 15); predominantly conserved mammalian LIPI N-glycosylation sites (63NNSL and 396NISS for human LIPI); active site “triad” residues (Ser159; Asp183; His253); disulfide bond residues (238 - 251; 275 - 286; 289 - 297; 436 - 455); and a 12 residue “active site lid”, which is shorter than for other lipases examined. Phylogenetic analyses supported a hypothesis that LIPI arose from a vertebrate LIPH gene duplication event within a mammalian common ancestral genome. In addition, LIPI, LIPH and PL-PLA1 genes were distinct from the vascular lipase (LIPG, LIPC and LPL) and pancreatic lipase (PL) gene families.

1. INTRODUCTION

Lipase I (LIPI; E.C.2.7.11.34), also known as phosphatidic acid-selective phospholipase A1β, PA-PLA1β, cancer-testis antigen 17 (CT17) or LPD lipase (PLDL), is a membrane-associated phospholipase catalyzing the production of fatty acids and lysophosphatidic acid (LPA) from phosphatidic acid [1,2]. LPA is a lipid mediator involved in diverse biological functions in the body [3]. Most of these functions are mediated by G protein-coupled receptors (GPCRs) specific to LPA, for which six GPCRs have been described [4]. A second membrane associated phosphatidic acid-selective phospholipase, lipase H (LIPH; E.C.2.7.11.30) (also known as phosphatidic acid-selective phospholipase A1α or PA-PLA1α), has also been identified as playing a major role in hair follicle cells, with autosomal recessive hypotrichosis (ARH) resulting from LIPH mutations, leading to the woolly hair hypotrichosis phenotype in human populations and sparse hair on the scalp [5-7]. A third membrane associated phosphatidic acid-selective phospholipase, phosphatidylserine specific phospholipase A1 (PS-PLA1), has also been described which hydrolyzes fatty acids at the sn-1 position of phosphatidylserine and 1-acyl-2-lysophosphatidylserine [8-10].

Human LIPI and mouse Lipi genes are expressed in the testis with LIPI found at the connecting piece of primary spermatocytes [1,2], although a specific role for LIPI in LPA signalling has not as yet been reported [10]. LIPI has been identified as a Ewing tumor-associated cancer/testis antigen (called CTA17), which is also expressed in testis and thyroid tissues [11,12]. The human LIPI gene spans more than 98 kilobases of DNA, comprises 10 coding exons on the reverse strand and is localized on chromosome 21 near a gene encoding the RNA binding motif protein 11 (RBM11) [13,14]. Mouse Lipi spans more than 45 kilobases of DNA, encodes 11 coding exons on the reverse strand of chromosome 16, and is also located near the gene encoding RNA binding motif protein 11 (RBM11) [2,14]. Mutations of the human LIPI (or LPDL) and mouse Lipi (or Lpdl) genes have been associated with dyslipidemia in humans and hypertriglyceridemia in mice [2]. In addition, a monosomic deletion model for the mouse chromosome 16 Lipi-Usp25 region exhibited a significant increase in fat mass, thickened subcutaneous fat and liver steatosis, when fed a high-fat diet [15]. Hesse and coworkers [16] have recently identified two LIPH/LIPI-like genes in the chicken genome with wide tissue expression profiles.

There have been few biochemical and structural studies of mammalian LIPI, however two reports have described amino acid sequences for human and mouse LIPI, derived from cDNA sequences, encoding 460 and 476 amino acids, respectively, containing N-terminal and lipase domains in each case [1,2]. Human LIPI (also called LPDL) exhibited 71% identity with mouse LIPI, and ~44% identity with LIPH and ~35% identity with vascular lipase sequences [lipoprotein lipase (LPL), endothelial lipase (EL) and hepatic lipase (HL)]. In common with the human and mouse LIPH amino acid sequences, the LIPI sequences were characterized by shortened “active site lid” motifs and exhibited a higher affinity for heparin binding than for LIPH.

This paper reports the predicted gene structures and amino acid sequences for several mammalian LIPI genes and proteins, the predicted secondary and tertiary structures for mammalian LIPI protein subunits, and the structural, phylogenetic and evolutionary relationships for these genes and enzymes with the vertebrate LIPH and PL-PLA1 gene families and with vertebrate vascular and pancreatic lipase gene families.

2. METHODS

2.1. Mammalian LIPI Gene and Protein Identification

BLAST (Basic Local Alignment Search Tool) studies were undertaken using web tools from the National Center for Biotechnology Information (NCBI) (http://blast. ncbi.nlm.nih.gov/Blast.cgi) [17]. Protein BLAST analyses used human and mouse LIPI amino acid sequences previously described [1,2] (Table 1). Non-redundant protein sequence databases for several mammalian and other vertebrate genomes were accessed from sources previously described [18]. Predicted LIPI-like protein sequences were obtained in each case and subjected to analyses of predicted protein and gene structures.

BLAT (BLAST-Like Alignment Tool) analyses were subsequently undertaken for each of the predicted vertebrate LIPI amino acid sequences using the University of California Santa Cruz (UCSC) Genome Browser [http:// genome.ucsc.edu/cgi-bin/hgBlat] [14] with the default settings to obtain the predicted locations for each of the vertebrate LIPI genes, including predicted exon boundary locations and gene sizes. This browser was also used to show alignments of LIPI genes from several vertebrate genomes (called Multiz alignments). Structures for human and mouse LIPI isoforms were obtained using the AceView website to examine predicted gene and protein structures [19]. Mammalian LIPI sequences were aligned using the ClustalW2 multiple sequence alignment program [20].

2.2. Predicted Structures and Properties of Mammalian LIPI Protein Subunits

Predicted secondary and tertiary structures for mammalian LIPI-like subunits were obtained using the PSIPRED v2.5 web site tools [21] and the SWISS MODEL web tools [swissmodel.expasy.org], respectively [22]. The reported tertiary structure for horse pancreatic lipase (PDB: 1hpl) [23] served as the reference for the predicted human, mouse and rat LIPI tertiary structures, with a modeling range of residues 10 to 447. Theoretical isoelectric points and molecular weights for mammalian LIPI subunits were obtained using Expasy web tools (http://au.expasy.org/tools/pi_tool.html). SignalP 3.0 web tools were used to predict the presence and location of signal peptide cleavage sites (http://www.cbs. dtu.dk/services/SignalP/) for each of the predicted mammalian LIPI sequences [24]. The NetNGlyc 1.0 Server was used to predict potential N-glycosylation sites for mammalian LIPI subunits (http://www.cbs.dtu.dk/services/ NetNGlyc/).

2.3. Phylogenetic Studies and Sequence Divergence

Alignments of mammalian LIPI, human, mouse and zebrafish LIPH (lipoprotein H) and human, mouse, rat, chicken and zebrafish PS-PLA1, HL (hepatic lipase), LPL (lipoprotein lipase), EL (endothelial lipase) protein sequences, as well as human, mouse and frog pancreatic lipases (PL) sequences (Table 1s) were assembled using BioEdit v.5.0.1, as previously described [25]. Alignment ambiguous regions were excluded prior to phy

logenetic analysis yielding alignments of 379 residues for comparisons of sequences (Table 1). Evolutionary distances were calculated using the Kimura option as previously described [18]. Phylogenetic trees were constructed from evolutionary distances using the neighborjoining method [25]. Tree topology was examined by the boot-strap method (100 bootstraps were applied) of resampling and only values that were highly significant (≥95) are shown [26].

3. RESULTS AND DISCUSSION

3.1. Alignments of Human and Other Mammalian LIPI Subunits

The deduced amino acid sequences for orangutan (Pongo abelii), gibbon (Nomascus leucogenys), marmotset (Callithrix jacchus) and rat (Rattus norvegicus) LIPI subunits are shown in Figure 1 together with the previously reported sequences for human (Homo sapiens) and mouse (Mus musculus) LIPI subunits (Table 1) [1,2].

Alignments of the human and other mammalian LIPI subunits examined showed between 61% - 99% sequence identities, suggesting that these are products of the same family of genes and proteins (Table 2). The amino acid sequence for human and other primate LIPI subunits contained 460 residues while other mammalian LIPI subunits contained 476 (mouse and rat) to 452 residues

(dog LIPI) (Figure 1; Table 1). The mouse and rat LIPI sequences differed in length from the primate LIPI sequences as a result of 16 additional residues at the amino terminus end. Several key amino acid residues for vertebrate LIPI were recognized (sequence numbers refer to human LIPI) (Figures 1 and 1s). These included the catalytic triad for the active site (Ser159; Asp183; His253) forming a charge relay network for substrate hydrolysis, similar to human lipoprotein lipase, other lipases and carboxylesterases [27,28]; a hydrophobic N-terminus signal peptide (residues 1 - 15), similar to that reported for rat hepatic lipase [29]; and disulfide bond forming residues (Cys238/Cys251; Cys275/Cys286; Cys289/ Cys297; and Cys436/Cys455) [1,2]. Identical residues were observed for each of the mammalian LIPI subunits for the active site triad and disulfide bond forming residues, however the N-terminus 15-residue signal peptide underwent some changes in sequence but retained predicted signal peptide properties (Figures 1 and 1s; Table 1). Two of the N-glycosylation sites predicted for human LIPI at Asn63-Asn64-Ser65 and at Asn396-397Ile- 398Ile (designated as sites 3 and 9, respectively) were retained for most of the 11 mammalian LIPI sequences examined, although predicted N-glycolsylation sites were observed at other positions for some sequences, including Asn23-Thr24-Thr52 (site 1) for mouse LIPI; Asn34-Arg35-Thr36 (site 2) for rat LIPI; Asn61-Phe62-

Figure 1. Amino acid sequence alignments for mammalian LIPI subunits. See Table 1 for sources of LIPI sequences; * shows identical residues for LIPI subunits; : similar alternate residues; . disimilar alternate residues; N-signal peptide residues are in red; Nglycosylation residues are in green; active site triad residues Ser; Asp; and His are in pink; phosphorylated human Ser25 is in khaki; disulfide bond Cys residues are in blue; predicted helix; predicted sheet; bold font shows known or predicted exon junctions; exon numbers refer to human LIPI gene; predicted “lid” covering the active site (human LIPI residues 239 - 250) are shown #####; Hu— human LIPI; Or—orangutan LIPI; Gi—gibbon LIPI; Ma—marmoset LIPI; Mo—mouse LIPH; Ra—rat LIPI.

Ser63 and Asn71-Phe72-Ser73 (site 4) for dog and panda LIPI, respectively (Table 3). Given the reported role of the N-glycosylated carbohydrate group in contributing to the stability and maintaining catalytic efficiency of a related enzyme (human carboxylesterase or CES1) [30], this property may be shared by mammalian LIPI as well. Human LIPI Ser25, which has been previously reported to undergo phosphorylation in response to DNA damage [31], has also been retained (but with Thr41 for mouse LIPI) for each of the mammalian LIPI sequences examined (Figure 1).

3.2. Alignments of Human LIPI and Other Lipase Subunits

Alignments of human LIPI, lipase H (LIPH) [32], phosphatidylserine specific phospholipase A1 (PS-PLA1) [8-10], endothelial lipase (EL) [18,33], hepatic lipase (HL) [34], lipoprotein lipase (LPL) [35] and pancreatic lipase (PL) [36] sequences are shown in Figure 2. The following key amino acid residues were observed for each of these lipases consistent with those observed for the mammalian LIPI sequences (see Table 1). These included the N-terminal signal peptide sequences, which were distinct for each lipase but retained the property as signal peptides; the active site triad residues aligning with LIPI Ser159, Asp183 and His253; the disulfide cysteine residues reported for mammalian LIPH and LIPI sequences (human LIPI Cys238/Cys251; Cys275/Cys286; Cys289/Cys297; and Cys436/Cys455), although human PS-PLA1 did not contain the last disulfide pair, and additional disulfide bonds were observed for EL, LPL and HL (corresponding to human EL Cys64/Cys77) and for human PL (corresponding to Cys20/Cys26 and Cys107/ Cys118); distinct N-glycosylation sites were predominantly observed for each of the lipase sequences examined; the active site “lid” sequences showed that LIPI, LIPH and PS-PLA1 exhibited fewer residues in each case (12 amino acids), in comparison with the other lipases (EL [19 residues]; LPL and HL [22 residues]; and PL [23 residues]; and a high basic amino acid content region was observed for human LIPI residues (Arg299 →Arg321] aligning with a heparin binding site (human EL 324Lys→333Lys) reported for human EL which binds the enzyme to heparan sulfate proteoglycans on the luminal side of endothelial cells [37,38]. The latter region for human LIPI may explain the enhanced heparin binding reported for LIPI, in compareson with LIPH, and the higher isoelectric point (pI) values observed for mammalian LIPI proteins (Table 1) [1].

3.3. Predicted Secondary and Tertiary Structures of Mammalian LIPI Subunits

Predicted secondary structures for mammalian LIPI sequences were compared in Figure 1, and similar α- helix and β-sheet structures were observed for all of the mammalian LIPI subunits examined. Consistent structures were particularly apparent near key residues or functional domains including the β-sheet and α-helix structures near the active site Ser159 (β4/α3) and His253 (α4) residues; and the conserved disulfide bonds at Cys275/Cys286 (near α4) and Cys436/Cys455 (near β14). Proximate to the active site histidine (His253) and lo-

Table 3. Known or predicted N-glycosylation sites for mammalian LIPI subunits.

Figure 2. Amino acid sequence alignments for human lipase I (LIPI), lipase H (LIPH), phosphatidylserine specific phospholipase A1 (PS-PLA1), endothelial lipase (EL), lipoprotein lipase (LPL), hepatic lipase (HL) and pancreatic lipase (PL). See Table 1 and Supplementary Table 1 for sources of human LIPI, LIPH, PS-PLA1, endothelial lipase (EL), lipoprotein lipase (LPL), hepatic lipase (HL) and pancreatic lipase (PL) sequences; * shows identical residues for subunits; : similar alternate residues; . dissimilar alternate residues; N-signal peptide residues are in red; known or predicted N-glycosylation residues are in green; active site triad residues Ser; Asp; and His are in pink; disulfide bond Cys residues are shown (C); predicted helix; predicted sheet; bold font shows known or predicted exon junctions; exon numbers refer to human LIPI gene; basic amino acid residues (R and K) located in the heparin binding region of EL, LPL and HL are shown; predicted “lid” resisdues covering the active site (human LIPI residues 238 - 251) are shown #####; the following domains were recognized for human LIPI: “lipase”: residues 18 - 300; “hinge”: residues 301 - 321; and “plat”: residues 322 - 460.

cated between two residues (Cys238/Cys251) forming disulfide intramolecular bonds are 12 amino acids forming the proposed “active site lid” structure for vertebrate LIPI [1,2]. In addition, eight β-sheets were observed at the LIPI C-terminus end, which is consistent with PLAT domain structures previously reported for horse pancreatic lipase (PL) [23]. It is apparent from these studies that the LIPI subunits examined have highly similar seconddary structures.

The tertiary structure for horse pancreatic lipase (PTL) is from [28]; predicted mouse, rat and human LIPI 3-D structures were obtained using the SWISS MODEL web site http://swissmodel.expasy.org and based on the reported structure for horse PTL (PDB: 1hpl); the rainbow color code describes the 3-D structures from the N-(blue) to C-termini (red color); N refers to amino-terminus; C refers to carboxyl terminus; the “lipase” and “plat” domains, the active site region and the “lid” covering the active site are shown.

Figure 3 describes predicted tertiary structures for human, mouse and rat LIPI sequences, in comparison with horse pancreatic lipase (PL) [23]. Identification of specific structures within the predicted LIPI sequences were based on the reported structure for horse PL which identifies a sequence of twisted β-sheets interspersed with several α-helical structures which are typical of the alphabeta hydrolase super-family. The active site LIPI triad was centrally located which is similar to that observed for other lipases [18,23,39] and carboxylesterase (human CES1) [40]. The major difference between LIPI and other lipases examined (see Figures 2 and 3) is the much smaller size of the “lid” region at positions 239 - 251, which may act as a surface loop that partially covers the opening to the catalytic triad and allows access to the

Figure 3. Tertiary structure for horse pancreatic lipase (PL) and predicted tertiary structures for mouse, rat and human LIPI subunits.

active site by LIPI substrates. This “lid” structure is readily apparent in the predicted structures for human, mouse and rat LIPI. These comparative studies of mammalian LIPI proteins suggest that the properties, structures and key sequences are substantially retained for the mammalian sequences examined. Figure labels.

3.4. Predicted Gene Locations and Exonic Structures for Mammalian LIPI Genes

Table 1 summarizes the predicted locations for mammalian LIPI genes based upon BLAT interrogations of several mammalian genomes using the reported sequences for human and mouse LIPI [1,2] and the predicted sequences for other mammalian LIPI proteins and the UCSC Genome Browser [14]. Human and mouse LIPI genes were located on human chromosome 21 and mouse chromosome 16, which are distinct to the gene locations for other lipases, including lipase H (LIPH) (human chromosome 3 and mouse chromosome 16); phosphatidylserine specific phospholipase A1 (PS-PLA1) (human chromosome 21 and mouse chromosome 16); hepatic lipase (LIPC) (human chromosome 15 and mouse chromosome 9); endothelial lipase (LIPG) (both human and mouse genes on chromosome 18); lipoprotein lipase (LPL) (both human and mouse genes on chromosome 8); and pancreatic lipase (PL) (human chromosome 10 and mouse chromosome 19), respectively (Tables 1 and 1s). Figure 1 summarizes the predicted exonic start sites for several mammalian LIPI genes with each having 10 or 11 (mouse and rat Lipi) exons, in identical or similar positions to those reported for the human LIPI and mouse Lipi genes [1,2,14]. Human LIPG, LIPC, LPL and PL genes contained 10, 9, 9 and 12 exons respectively, which are in similar positions for several exons of vertebrate LIPI genes, suggesting that these are related genes (Figure 2). Figure 4" target="_self"> Figure 4 presents the structures for human LIPI and mouse Lipi transcripts, with the major transcript isoforms being designnated as NM_198996 and NM_001252513, respectively [1,2,14]. The transcripts were 1.7 and 2.1 kilobases in length respectively, with 10 introns and 11 exons in each case.

Figure 2s shows a UCSC Genome Browser Comparative Genomics track that shows evolutionary conservation and alignments of the nucleotide sequences for the human LIPI gene, including the 5’-flanking, 5’-untranslated, intronic, exonic and 3’-untranslated regions of this gene, with the corresponding sequences for 8 vertebrate genomes, including 4 eutherian mammals (rhesus monkey, mouse, elephant and dog), a marsupial (opossum), a bird (chicken), frog and zebrafish genomes. Extensive conservation was observed only for the mammalian LIPI genes, particularly for the rhesus LIPI gene and for exonic sequences for eutherian mammalian LIPI genes. In contrast with the eutherian mammalian genomes examined, other vertebrate genomes exhibited

Figure 4. Gene structures and isoforms for the human LIPI and mouse Lipi genes.

few conserved sequences, which indicates that only the mammalian LIPI genes were predominantly conserved throughout vertebrate evolution.

Derived from AceView website [31]; the major isoform variants are shown with capped 5’- and 3’-ends for the predicted mRNA sequences; introns and coding exons are shown; the direction for transcription is shown; 3’UTR refers to 3’-untranslated region; a scale is shown in base pairs (bps); coding exons are in pink; untranslated 5’ and 3’ regions are shown as open rectangles.

3.5. Phylogeny and Divergence of Mammalian LIPI and other Vertebrate Lipase Sequences

A phylogenetic tree (Figure 5) was calculated by the progressive alignment of human and other vertebrate LIPI amino acid sequences with human, mouse, rat, chicken and zebra fish LIPH; human, mouse, rat, chicken, lizard and zebra fish PS-PLA1; human, mouse and zebra fish hepatic lipase (HL) and endothelial lipase (EL); human, mouse and stickleback (fish) lipoprotein lipase (LPL); and human, mouse and frog pancreatic lipase (PL) sequences. The phylogram showed clustering of the mammalian LIPI sequences which were distinct from the vertebrate LIPH and PS-PLA1 sequences; and from other vertebrate sequences for vascular lipases (HL, EL and LPL) and pancreatic lipase (PL) vertebrate lipase families. In addition, LIPH and LIPI sequences clustered together, which is consistent with these genes being products of a recent duplication event during mammalian evolution. Overall, the data suggested that the mammalian LIPI gene arose from a gene duplication event of an ancestral LIPH-like gene, resulting in two separate lines of mammalian gene evolution for these genes, namely LIPI and the LIPH genes. This is supported by the comparative biochemical and genomic evidence for mammalian LIPI and vertebrate LIPH genes and encoded proteins, which share several key features of protein and gene structure, including having similar alpha-beta hydrolase secondary and tertiary structures.

The tree is labeled with the gene name and the name of the vertebrate. Note the major cluster for the mammalian LIPI sequences and the separation of these sequences from vertebrate LIPH (lipase H), PS-PLA1, human, mouse and zebrafish HL (hepatic lipase), EL (endothelial lipase) and LPL (lipoprotein lipase) sequences and human, mouse and frog PL (pancreatic lipase) sequences. See Tables 1 and 1s for details of sequences and gene locations. A genetic distance scale is shown (% amino acid substitutions). The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates is shown. Only replicate values of 95 or more, which are highly significant, are shown with 100 bootstrap replicates performed in each case.

3.6. Conclusion

The results of this study suggest that mammalian LIPI genes and encoded LIPI enzymes represent a distinct alpha-beta hydrolase-like gene and enzyme family which share key conserved sequences and structures that have been reported for human LIPH [5-7], PS-PLA1 [8-10], the vascular lipase gene families, hepatic lipase (HL) [41, 42], endothelial lipase (EL) [18,33] and lipoprotein lipase (LPL) [35], and for pancreatic triglyceride lipase (PL) [36]. LIPI is a membrane associated phosphatidic acid-selective phospholipase catalysing the production of fatty acids and lysophosphatidic acid. Bioinformatic methods were used to predict the amino acid sequences, secondary and tertiary structures and gene locations for LIPI genes and encoded proteins using data from several vertebrate genome projects. Mammalian LIPI protein subunits shared 61% - 99% sequence identities and exhibited sequence alignments and identities for key LIPI amino acid residues as well as extensive conservation of predicted secondary and tertiary structures with those

Figure 5. Phylogenetic tree of mammalian LIPI sequences with vertebrate LIPH, PS-PLA1, human, mouse and zebra fish hepatic lipase (HL) and endothelial lipase (EL), human, mouse and stickleback lipoprotein lipase (LPL), and human, mouse and frog pancreatic lipase (PL) amino acid sequences.

previously reported for horse pancreatic lipase, with “Nsignal peptide”, “lipase” and “plat” structural domains. Phylogenetic analyses demonstrated the relationships and potential evolutionary origins of the mammalian LIPI family of genes from a duplication of a vertebrate LIPH ancestral gene, for which duplicated genes have been reported for chicken LIPH genes [16]. These studies indicated that LIPI genes have appeared early in eutherian mammalian evolution.

4. ACKNOWLEDGEMENTS

The expert assistance and advice of Dr. Bharet Patel from Griffith University is gratefully acknowledged.

REFERENCES

  1. Hiramatsu, T., Sonoda, H., Takanezawa, Y., Morikawa, R., Ishida, M., Kasahara, K., Sanai, Y., Taguchi, R., Aoki, J. and Arai, H. (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta. Journal of Biological Chemistry, 278, 49438-49447. doi:10.1074/jbc.M213018200
  2. Wen, X.Y., Hegele, R.A., Wang, J., Wang, D.Y., Cheung, J., Wilson, M., Yahyapour, M., Bai, Y., Zhuang, L., Skaug, J., Young, T.K., Connelly, P.W., Koop, B.F., Tsui, L.C. and Stewart, A.K. (2003) Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans. Human Molecular Genetics, 12, 1131-1143. doi:10.1093/hmg/ddg124
  3. Moolenaar, W.H. (1995) Lysophatidic acid, a multifunctional phospholipid messenger. The Journal of Biological Chemistry, 270, 12949-12952.
  4. Hama, K. and Aoki, J. (2010) LPA3, a unique G proteincoupled receptor for lysophosphatidic acid. Progress in Lipid Research, 49, 335-342. doi:10.1016/j.plipres.2010.03.001
  5. Aoki, J., Inoue, A. and Okudaira, S. (2008) Two pathways for lysophosphatidic acid production. Biochimica et Biophysica Acta, 1781, 513-518.
  6. Shimomura, Y., Wajid, M., Petukhova, L., Shapiro, L. and Christiano, A.M. (2009) Mutations in the lipase H gene underlie autosomal recessive woolly hair/hypotrichosis. Journal of Investigative Dermatology, 129, 622- 628. doi:10.1038/jid.2008.290
  7. Shinkuma, S., Akiyama, M., Inoue, A., Aoki, J., Natsuga, K., Nomura, T., Arita, K., Abe, R., Ito, K., Nakamura, H., Ujiie, H., Shibaki, A., Suga, H., Tsunemi, Y., Nishie, W. and Shimizu, H. (2010) Prevalent LIPH founder mutations lead to loss of P2Y5 activation ability of PAPLA1alpha in autosomal recessive hypotrichosis. Human Mutation, 31, 602-610.
  8. Sato, T., Aoki, J., Nagai, Y., Dohmae, N., Takio, K., Doi, T., Arai, H. and Inoue, K. (1997) Serine phospholipidspecific phospholipase A that is secreted from activated platelets. The Journal of Biological Chemistry, 272, 2192- 2198. doi:10.1074/jbc.272.4.2192
  9. Wen, X.Y., Hegele, R.A., Wang, J., Wang, D.Y., Cheung, J., Wilson, M., Yahyapour, M., Bai, Y., Zhuang, L., Skaug, J., Young, T.K., Connelly, P.W., Koop, B.F., Tsui, L.C. and Stewart, A.K. (2003) Identification of a novel lipase gene mutated in lpd mice with hypertriglyceridemia and associated with dyslipidemia in humans. Human Molecular Genetics, 12, 1131-1143. doi:10.1093/hmg/ddg124
  10. Aoki, J., Inoue, A., Makide, K., Saiki, N. and Arai, H. (2007) Structure and function of extracellular phospholipase A1 belonging to the pancreatic lipase gene family. Biochimie, 89, 197-204. doi:10.1016/j.biochi.2006.09.021
  11. Schmiedel, B.J., Hutter, C., Hesse, M. and Staege, M.S. (2011) Expression of multiple membrane-associated phospholipase A1 beta transcript variants and lysophosphatidic acid receptors in Ewing tumour cells. Molecular Biology Reports, 38, 4619-4628. doi:10.1007/s11033-010-0595-z
  12. Foell, J.L., Hesse, M., Volkmer, I., Schmiedel, B.J., Neumann, I. and Staege, M.S. (2008) Membrane-associated phospholipase A1 beta (LIPI) is an Ewing tumour-associated cancer-testis antigen. Pediatric Blood Cancer, 51, 228- 234. doi:10.1002/pbc.21602
  13. Hattori, M., Fujiyama, A., Taylor, T.D., Watanabe, H., Yada, T., Park, H.S., Toyoda, A. and Ishii, K. (2000) The DNA sequence of human chromosome 21. Nature, 405, 311-319. doi:10.1038/35012518
  14. Kent, W.J., Sugnet, C.W., Furey, T.S., Roskin, K.M., Pringle, T.H., Zahler, A.M. and Haussler, D. (2003) The human genome browser at UCSC. Genome Research, 12, 994- 1006.
  15. Migdalska, A.M., van der Weyden, L., Inmail, O. and White, J.K. (2012) Modeling partial monosomy for human chromosome 21q11.2-q21.1 reveals haplosufficient genes influencing behaviour and fat deposition. PLoS One, 7, e29681. doi:10.1371/journal.pone.0029681
  16. Hesse, M., Willscher, E., Schmiedel, B.J., Posch, S., Golbik, R.P. and Staege, M.S. (2012) Sequence and expression of the chicken membrane-associated phospholipases A1 alpha (LIPH) and beta (LIPI). Molecular Biology Reports, 39, 761-769. doi:10.1007/s11033-011-0796-0
  17. Altschul, F., Vyas, V., Cornfield, A., Goodin, S., Ravikumar, T.S., Rubin, E.H. and Gupta, E. (1997) Basic local alignment search tool. Journal of Molecular Biology, 215, 403-410.
  18. Holmes, R.S., VandeBerg, J.L. and Cox, L.A. (2011) Vertebrate endothelial lipase: Comparative studies of an ancient gene and protein in vertebrate evolution. Genetica, 139, 291-304. doi:10.1007/s10709-011-9549-1
  19. Thierry-Mieg, D. and Thierry-Mieg, J. (2006) AceView: A comprehensive cDNA-supported gene and transcripts annotation. Genome Biology, 7, S12. doi:10.1186/gb-2006-7-s1-s12
  20. Larkin, M.A., Blackshields, G., Brown, N.P., Chenna, R., McGettigan, P.A., McWilliam, H., Valentin, F., Wallace, I.M., Wilm, A., Lopez, G., Clustal, W. and Clustal, X. (2007) Version 2.0. Bioinformatics, 23, 2947-2948. doi:10.1093/bioinformatics/btm404
  21. McGuffin, L.J., Bryson, K. and Jones, D.T. (2000) The PSIPRED protein structure prediction server. Bioinformatics, 16, 404-405. doi:10.1093/bioinformatics/16.4.404
  22. Kopp, J. and Schwede, T. (2004) The SWISS-MODEL repository of annotated three-dimensional protein structure homology models. Nucleic Acids Research, 32, D230-D234. doi:10.1093/nar/gkh008
  23. Bourne, Y., Martinez, C., Kerfelec, B., Lombardo, D., Chapus, C. and Cambillau, C. (1994) Horse pancreatic lipase. The crystal structure refined at 2.3-A resolution. Journal of Molecular Biology, 238, 709-732. doi:10.1006/jmbi.1994.1331
  24. Emmanuelsson, O., Brunak, S., von Heijne, G. and Nielson, H. (2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nature Protocols, 2, 953-971. doi:10.1038/nprot.2007.131
  25. Saitou, N. and Nei, M. (1987) The neighbour-joining method: A new method for reconstructing phylogenetic trees. Molecular Biology and Evolution, 4, 406-411.
  26. Felsenstein, J. (1985) Confidence limits on phylogenies: An approach using the bootstrap. Evolution, 39, 783-789. doi:10.2307/2408678
  27. Emmerich, J., Beg, O.U., Peterson, J., Previato, L., Brunzell, J.D., Brewer Jr., H.B. and Santamarina-Fojo, S. (1992) Human lipoprotein lipase. Analysis of the catalytic triad by site-directed mutagenesis of Ser-132, Asp-156, and His-241. The Journal of Biological Chemistry, 267, 4161-4165.
  28. Cygler, M., Schrag, J.D., Sussman, J.L., Harel, M., Silman, I., Gentry, M.K. and Dostor, B.P. (1993) Relationship between sequence conservation and three-dimensional structure in a large family of esterases, lipases and related proteins. Protein Science, 2, 366-382. doi:10.1002/pro.5560020309
  29. Laposata, E.A., Laboda, H.M., Glick, J.M. and Strauss, J.F. (1987) Hepatic lipase. Synthesis, processing, and secretion by isolated rat hepatocytes. The Journal of Biological Chemistry, 262, 5333-5338.
  30. Kroetz, D.L., McBride, O.W. and Gonzalez, F.J. (1993) Glycosylation-dependent activity of Baculovirus-expressed human liver carboxylesterases: cDNA cloning and characterization of two highly similar enzyme forms. Biochemistry, 32, 11606-11617. doi:10.1021/bi00094a018
  31. Matsuoka, S., Ballif, B.A., Smogorzewska, A., McDonald, E.R., Hurov, K.E., Luo, J., Bakalarski, C.E. and Zhao, Z. (2007) ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science, 316, 1160-1166. doi:10.1126/science.1140321
  32. Jin, W., Broedl, U.C., Monajemi, H., Glick, J.M., Rader, D.J. and Lipase, H. (2002) A new member of the triglyceride lipase family synthesized by the intestine. Genomics, 80, 268-273. doi:10.1006/geno.2002.6837
  33. Jaye, M., Lynch, K.J., Krawiec, J., Marchadier, D., Maugeais, C., Doan, K., South, V., Amin, D., Perrone, M. and Rader, D.J. (1999) A novel endothelial-derived lipase that modulates HDL metabolism. Nature Genetics, 21, 424-428. doi:10.1038/7766
  34. Martin, G.A., Busch, S.J., Meredith, G.D., Cardin, A.D., Blankenship, D.T., Mao, S.J.T., Rechtin, A.E., Woods, C.W., Racke, M.M., Schafer, M.P., Fitzgerald, M.C., Burke, D.M., Flanagan, M.A. and Jackson, R.L. (1988) Isolation and cDNA sequence of human postheparin plasma hepatic triglyceride lipase. The Journal of Biological Chemistry, 263, 10907-10914.
  35. Wion, K.L., Kirchgessner, T.G., Lusis, A.J., Schotz, M.C. and Lawn, R.M. (1987) Human lipoprotein lipase complementary DNA sequence. Science, 235, 1638-1641. doi:10.1126/science.3823907
  36. Lowe, M.E. (2002) The triglyceride lipases of the pancreas. The Journal of Lipid Research, 43, 2007-2016. doi:10.1194/jlr.R200012-JLR200
  37. Hill, J.S., Yang, D., Nikazy, J., Curtiss, L.K., Sparrow, J.T. and Wong, H. (1998) Subdomain chimeras of hepatic lipase and lipoprotein lipase. Localization of heparin and cofactor binding. The Journal of Biological Chemistry, 273, 30979-30984. doi:10.1074/jbc.273.47.30979
  38. Sendak, R.A. and Bensadoun, A. (1998) Identification of a heparin-binding domain in the distal carboxyl-terminal region of lipoprotein lipase by site-directed mutagenesis. The Journal of Lipid Research, 39, 1310-1315.
  39. Winkler, F.K., D’Arcy, A. and Hunziker, W. (1990) Structure of human pancreatic lipase. Nature, 343, 771-774. doi:10.1038/343771a0
  40. Bencharit, S., Morton, C.L., Xue, Y., Potter, P.M. and Redinbo, M.R. (2003) Structural basis of heroin and cocaine metabolism by a promiscuous human drug-processing enzyme. Nature Structural & Molecular Biology, 10, 349- 356. doi:10.1038/nsb919
  41. Datta, S., Luo, C.C., Li, W.H., Van Tuinen, P., Ledbetter, D.H., Brown, M.A., Chen, S.H., Liu, S. and Chan, L. (1988) Human hepatic lipase. Cloned cDNA sequence, restriction fragment length polymorphisms, chromosomal localization, and evolutionary relationships with lipoprotein lipase and pancreatic lipase. The Journal of Biological Chemistry, 263, 1107-1110.
  42. Cai, S.J., Wong, D.M., Chen, S.H. and Chan, L. (1989) Structure of the human hepatic triglyceride lipase gene. Biochemistry, 28, 8966-8971. doi:10.1021/bi00449a002

SUPPLEMENT

Figure 1s. Amino acid sequence alignments for mammalian LIPI subunits. See Table 1 for sources of LIPI sequences; three regions for vertebrate LIPI sequences are shown, including active site (*) and lid sequences; amino acids are color coded: yellow for proline (P); S (serine); green for hydrophilic amino acids, S (serine), Q (glutamine), N (asparagine), and T (threonine); brown for glycine (G); light blue for hydrophobic amino acids, L (leucine), I (isoleucine), V (valine), M (methionine), W (tryptophan); dark blue for amino acids, T (tyrosine) and H (histidine); purple for acidic amino acids, E (glutamate) and D (aspartate); and red for basic amino acids, K (lysine) and R (arginine).

Figure 2s. Comparative sequences for vertebrate LIPI genes. Derived from the UCSC Genome Browser using the Comparative Genomics track to examine alignments and evolutionary conservation of vertebrate LIPI gene sequences; genomic sequences aligned for this study included rhesus, mouse, dog, elephant, a marsupial (opossum), bird (chicken), amphibian (frog) and fish (zebra fish); sequence identity is indicated by the green color; exons are numbered; note the conservation of mammalian LIPI exons.

NOTES

*Mammalian LIPI genes and proteins.